__timestamp | Amneal Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 449634000 | 27632226 |
Thursday, January 1, 2015 | 499226000 | 97707000 |
Friday, January 1, 2016 | 597455000 | 129037000 |
Sunday, January 1, 2017 | 526178000 | 151332000 |
Monday, January 1, 2018 | 716403000 | 158719000 |
Tuesday, January 1, 2019 | 352997000 | 170104000 |
Wednesday, January 1, 2020 | 628393000 | 192195000 |
Friday, January 1, 2021 | 768973000 | 220706000 |
Saturday, January 1, 2022 | 784708000 | 204426000 |
Sunday, January 1, 2023 | 820565000 | 133788000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have been vying for dominance in gross profit generation over the past decade. From 2014 to 2023, Amneal consistently outperformed Travere, with its gross profit peaking at approximately 820 million in 2023, a staggering 500% increase from Travere's 134 million in the same year. This trend highlights Amneal's robust growth strategy and market penetration. Notably, Amneal's gross profit surged by 75% from 2014 to 2023, while Travere's increased by 384%, albeit from a much smaller base. The data underscores Amneal's stronghold in the industry, yet Travere's rapid growth trajectory suggests a promising future. As the pharmaceutical sector continues to evolve, these insights provide a glimpse into the financial health and strategic direction of these two key players.
Gross Profit Analysis: Comparing Eli Lilly and Company and Amneal Pharmaceuticals, Inc.
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Incyte Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Corcept Therapeutics Incorporated or Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis